Does DUVELISIB Cause Decreased appetite? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Decreased appetite have been filed in association with DUVELISIB (COPIKTRA). This represents 2.8% of all adverse event reports for DUVELISIB.
21
Reports of Decreased appetite with DUVELISIB
2.8%
of all DUVELISIB reports
2
Deaths
8
Hospitalizations
How Dangerous Is Decreased appetite From DUVELISIB?
Of the 21 reports, 2 (9.5%) resulted in death, 8 (38.1%) required hospitalization.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for DUVELISIB.
What Other Side Effects Does DUVELISIB Cause?
Product use in unapproved indication (162)
Diarrhoea (110)
Death (89)
Fatigue (75)
Prescribed underdose (63)
Off label use (57)
Nausea (49)
Pneumonia (40)
Pyrexia (40)
Malignant neoplasm progression (38)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which DUVELISIB Alternatives Have Lower Decreased appetite Risk?
DUVELISIB vs DYDROGESTERONE
DUVELISIB vs EBASTINE
DUVELISIB vs ECALLANTIDE
DUVELISIB vs ECONAZOLE
DUVELISIB vs ECULIZUMAB